From 2005 until 2018 Dr. Cobuzzi held a variety of senior roles in Corporate Development, R&D and Operations at Endo International Plc, including most recently as President, Endo Ventures Limited in Dublin, Ireland from 2015 until 2018. Prior to Endo, he was with Adolor Corporation from 2001 until 2005. He began his career in 1995 at AstraMerck in clinical operations before joining Centocor (a subsidiary of Johnson & Johnson) in Worldwide Regulatory Affairs from 1999 to 2001. Dr. Cobuzzi currently serves as a Venture Partner for Sunstone Life Science Ventures and also is Chairman of Sunstone’s Business Development Board. He was previously a member of the U.S. Department of Commerce’s Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services, and served as a board member for two development-stage medical device companies. Dr. Cobuzzi holds an AB in Biochemistry and Art History from Colby College and a PhD in Molecular and Cellular Biochemistry from Loyola University Chicago. He was a post-doctoral fellow in the Department of Experimental Therapeutics at the Roswell Park Cancer Institute in Buffalo, N.Y.

Prior to joining Diffusion, Bill spent eight years as an associate at the law firm of Dechert LLP, counseling clients in a broad range of transactions and other matters, including serving as outside counsel to Diffusion in connection with the Company’s reverse merger in 2016 and several subsequent financings. Bill received a JD from the University of Pennsylvania School in Law, a MSF (Master of Science in Finance) from Villanova University, and a BA in Economics from Tufts University. Bill is licensed to practice law in the Commonwealth of Pennsylvania, where he lives with his dog, Stamos.

Ted joined Diffusion from Lannett, a generic pharmaceutical company, where he served as Director of Financial Planning & Analysis. While at Lannett, he worked on the acquisition and integration of Kremers Urban, assisted in various debt and equity capital transactions, and supported the Investor Relations activity in addition to leading the FP&A organization. Prior to Lannett, Ted worked as a contractor with various companies, such as CSL Behring, as financial support for CSL’s commercial organization. He began his career with Lockheed Martin as a member of their independent cost estimating (ICE) group before joining various companies such as Intuit, Medscape and The Corporate Marketplace (TCMPi) in financial leadership positions. Ted holds a Bachelor of Science in Accounting from the University of Rhode Island and an MBA from Babson’s Olin Graduate School of Business where he graduated Magna Cum Laude.

Laura earned her SHRM-SCP credentials from the Society for Human Resource Management in 2022. She is based in the suburbs of Philadelphia, PA where she lives with her feline friends, Ivy and Luna.